Amgen (NASDAQ:AMGN) has completed its tender offer for all issued and outstanding shares of Nuevolution AB. 97.6% of the shares have been tendered. Settlement should happen no later than July 15.
It intends to initiate compulsory acquisition proceedings for all non-tendered shares.
Date: July 15, 2019
Source: seekingalpha
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.